Suppr超能文献

终末期肾病患者血浆中心房利钠肽、精氨酸加压素及肾素-血管紧张素系统激素的浓度

Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.

作者信息

Elias A N, Vaziri N D, Pandian M R, Kaupke J

机构信息

Department of Medicine, University of California, Irvine.

出版信息

Int J Artif Organs. 1989 Mar;12(3):153-8.

PMID:2526100
Abstract

Plasma concentrations of atrial natriuretic peptide (ANP), arginine vasopressin (AVP), plasma renin activity (PRA) and aldosterone, were measured before and after 3 h of hemodialysis in 9 patients with end-stage renal disease on maintenance hemodialysis. Hormone concentrations were also determined in the same patients on a separate occasion after 1 h of ultrafiltration (UF). Plasma concentrations of ANP were significantly higher in the patients with ESRD than in a normal reference population and declined after both 1 h and 3 h of hemodialysis. Plasma concentrations of ANP failed to exhibit a significant decline after 1 h of UF. Plasma AVP concentrations were not significantly different after either hemodialysis or UF, while plasma aldosterone concentrations fell with hemodialysis. The decline in plasma aldosterone concentrations paralleled the decrease in dialysis-induced fall in serum potassium concentrations. There was no correlation between the blood pressures, heart rate, interdialytic weight gain and estimated fluid overload and any of the hormones measured except for the plasma renin activity (PRA) which correlated significantly with the systolic blood pressure. The data suggest that ANP may not be a major factor in blood pressure regulation in normotensive patients with ESRD and its elevation in patients with ESRD is most likely due to fluid overload and atrial distention as well as a possible reduction in its metabolic clearance in renal insufficiency. The fall in plasma ANP following hemodialysis is not due to its removal by dialysis but is most likely due to a reduction in ANP production caused by dialysis-induced correction of hypervolemia.

摘要

对9例维持性血液透析的终末期肾病患者,在血液透析3小时前后测定血浆心钠素(ANP)、精氨酸加压素(AVP)、血浆肾素活性(PRA)和醛固酮水平。在同一批患者单独一次超滤(UF)1小时后也测定了激素水平。终末期肾病患者的血浆ANP水平显著高于正常参考人群,且在血液透析1小时和3小时后均下降。超滤1小时后血浆ANP水平未出现显著下降。血液透析或超滤后血浆AVP水平无显著差异,而血液透析后血浆醛固酮水平下降。血浆醛固酮水平的下降与透析引起的血清钾浓度下降平行。血压、心率、透析间期体重增加和估计的液体超负荷与所测的任何激素之间均无相关性,但血浆肾素活性(PRA)与收缩压显著相关。数据表明,ANP可能不是血压正常的终末期肾病患者血压调节的主要因素,其在终末期肾病患者中的升高很可能是由于液体超负荷和心房扩张,以及肾功能不全时其代谢清除率可能降低。血液透析后血浆ANP的下降不是由于透析清除,而是很可能由于透析诱导的高血容量纠正导致ANP产生减少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验